Most Solid Tumor Patients Have ‘Adequate’ Response to COVID-19 Vaccination, Regardless of Treatment
Responses in cancer patients were noninferior to responses in patients without cancer.
COVID19 Vaccine
BNT162b2 Elicits Lower Antibody Levels Than mRNA-1273 Vaccine
Levels of IgG to SARS-CoV-2 spike receptor binding domain also lower with BNT162b2 for those aged 50 years and older versus younger than 50.
COVID-19 Vaccine Effectiveness Changing With Delta Predominance
Increasing prevalence of the delta variant was linked to a decline in vaccine protection against SARS-CoV-2 infection but not hospitalization or death.
Interim Data Show No Increase in Serious Outcomes Post-COVID-19 Vaccination
The incidence of ischemic stroke, appendicitis, or acute myocardial infarction were not increased 1 to 21 days after mRNA COVID-19 vaccination.
mRNA COVID-19 Vaccines Immunogenic in Immunosuppressed Patients
Titers of anti-S IgG were lower for patients with chronic inflammatory disease receiving glucocorticoids or B-cell depleting therapy.
Lung Cancer Patients Have Lower Antibody Response to COVID-19 Vaccination
Researchers are evaluating whether specific anticancer therapies affect antibody levels.
Odds of COVID-19 Hospitalization Lower After Vaccination
Vaccinated individuals who tested positive for SARS-CoV-2 were more likely to be completely asymptomatic.
Most Highly Allergic People Can Be Safely Immunized Against COVID-19
About 98% of patients from the highly allergic group had no immediate allergic event after the first dose of the BNT162b2 vaccine.
Which Cancer Patients Need a COVID-19 Booster Shot Most?
NCCN guidance says several groups should be considered eligible immediately for a third dose of either of the mRNA vaccines.
15 Million COVID-19 Vaccine Doses Wasted in U.S. Since March 1
Reasons why doses may be marked as wasted include a cracked vial, an error diluting the vaccine, a freezer malfunction.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...